Comparison of RDW-SD and RDW -CV in Chronic Kidney Disease Patients Before and After Hemodialysis

Authors

  • Dzaki Ahmad Fahrezi Amus Departemen Patologi Klinik, Fakultas Kedokteran, Universitas Tadulako, Palu, 94119, Indonesia
  • Haerani Harun Program Studi Kedokteran, Fakultas Kedokteran, Universitas Tadulako, Palu, 94119, Indonesia
  • Jeremy Tanan Departemen Patologi Klinik, Fakultas Kedokteran, Universitas Tadulako, Palu, 94119, Indonesia
  • Rahma Departemen Ilmu Kesehatan Anak, Fakultas Kedokteran, Universitas Tadulako, Palu, 94119, Indonesia
  • Nur Syamsi Departemen Farmakologi, Fakultas Kedokteran, Universitas Tadulako, Palu, 94119, Indonesia
  • Christin Rony Nayoan Departemen Farmakologi, Fakultas Kedokteran, Universitas Tadulako, Palu, 94119, Indonesia

DOI:

https://doi.org/10.29103/averrous.v12i1.26722

Keywords:

Chronic Kidney Disease, hemodialysis, RDW-CV, RDW-SD

Abstract

Red Cell Distribution Width (RDW) is a prognostic biomarker in chronic kidney disease (CKD), reported as RDW-SD (absolute) and RDW-CV (relative). This study directly compares changes in RDW-SD versus RDW-CV before and after a single hemodialysis (HD) session. This pre-post observational study involved 30 adult CKD patients undergoing routine HD. Blood samples were taken pre-HD and one hour post-HD. RDW-SD, RDW-CV, and other hematological parameters were analyzed using a hematology analyzer (Wilcoxon test). Median RDW-SD was 44.40 fL pre-HD vs. 43.80 fL post-HD (p=0.186); median RDW-CV was 14.35% pre-HD vs. 14.30% post-HD (p=0.052). Neither showed significant acute changes, although hemoglobin and leukocytes increased while platelets decreased. A single HD session does not significantly alter RDW-SD or RDW-CV, confirming both parameters reflect chronic disease status rather than acute procedural effects. Clinical implications: These preliminary findings suggest that RDW-SD and RDW-CV may be considered potential long-term prognostic markers, although this requires confirmation in larger studies.

References

[1] K. Kalantar-Zadeh, T. H. Jafar, D. Nitsch, B. L. Neuen, and V. Perkovic, “Chronic Kidney Disease,” Lancet, vol. 398, no. 10302, pp. 786–802, Aug. 2021, doi: 10.1016/S0140-6736(21)00519-5.

[2] D. D. W. Kim, M. Lee, K. J. Lee, Y. H. Lee, S. J. Shin, and H. E. Yoon, “The Combined Clinical Impact of Red Blood Cell Distribution Width and Vascular Calcification on Cardiovascular Events and Mortality in Patients With Endstage Kidney Disease,” Kidney Res. Clin. Pract., vol. 41, no. 3, pp. 351–362, 2022, doi: 10.23876/j.krcp.21.078.

[3] S. Roumeliotis et al., “Red Blood Cell Distribution Width is Associated with Deterioration of Renal Function and Cardiovascular Morbidity and Mortality in Patients with Diabetic Kidney Disease,” Life, vol. 10, no. 11, p. 301, 2020, doi: 10.3390/life10110301.

[4] A. Agarwal and F. Anjum, Hemodialysis. StatPearls [Internet]: StatPearls Publishing, 2026. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK563296/

[5] A. K. Bello et al., “Epidemiology of Haemodialysis Outcomes,” Nat. Rev. Nephrol., vol. 18, no. 6, pp. 378–395, 2022, doi: 10.1038/s41581-022-00542-7.

[6] S. Lulumanin dan D. S. Fahrurodzi, “Analisis Determinan Penyakit Gagal Ginjal Kronis di Indonesia Berdasarkan Data Survei Kesehatan Indonesia Tahun 2023,” Infokes J. Ilm. Rekam Medis dan Inform. Kesehat., vol. 15, no. 2, pp. 86–94, Aug. 2025, doi: 10.47701/kz1ava25.

[7] M. Rezal, “Hubungan Adekuasi Hemodialisis Dengan Kualitas Hidup Pasien Gagal Ginjal Kronis Di Rumah Sakit Anutapura Palu,” J. Innov. Creat., vol. 6, no. 1, pp. 2866–2873, 2026, doi: 10.31004/joecy.v6i1.7195.

[8] H. Widiani, “Penyakit Ginjal Kronik Stadium V Akibat Nefrolitiasis,” Intisari Sains Medis, vol. 11, no. 1, pp. 160–164, 2020, doi: 10.15562/ism.v11i1.680.

[9] J. Zhang, X. Lu, J. Feng, S. Wang, and H. Li, “Prognostic Value of Red Cell Distribution Width and Mean Corpuscular Volume on Mortality in Hemodialysis Patients,” Semin. Dial., vol. 36, no. 1, pp. 18–23, 2023, doi: 10.1111/sdi. 13109.

[10] S. Roumeliotis et al., “Association of Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio with Calcification and Cardiovascular Markers in Chronic Kidney Disease,” Metabolites, vol. 13, no. 2, p. 303, Feb. 2023, doi: 10.3390/metabo13020303.

[11] S. Sarkar, S. Kannan, P. Khanna, and A. K. Singh, “Role of Red Blood Cell Distribution Width, as a Prognostic Indicator in COVID‐19: A Systematic Review and Meta‐Analysis,” Rev. Med. Virol., vol. 32, no. 2, p. e2264, 2022, doi: 10.1002/rmv. 2264.

[12] J. Feng et al., “Association Between RDW-SD and Prognosis Across Glycemic Status in Patients with Dilated Cardiomyopathy,” BMJ Open Diabetes Res. Care, vol. 12, no. 6, p. e004478, 2024, doi: 10.1136/bmjdrc-2024-004478.

[13] K. Miyataka et al., “Red Blood Cell Distribution Width is Associated with Renal Tubular Injury in Individuals with Type 2 Diabetes,” J. Diabetes Investig., vol. 16, no. 12, pp. 2191–2200, Dec. 2025, doi: 10.1111/jdi. 70149.

[14] W. Jian, X. Shen, Z. Zheng, Z. Wu, Y. Shi, and J. Liu, “Association Between Red Blood Cell Distribution Width and Coronary Calcification in Patients Referred for Invasive Coronary Angiography,” Angiology, vol. 76, no. 7, pp. 690–698, Aug. 2025, doi: 10.1177/00033197241238509.

[15] N. Nakamura, H. Tsunemine, R. Ikunari, Y. Tanaka, and N. Arima, “Red Blood Cell Distribution Width is A Useful Biomarker to Predict Bleeding and Thrombosis Risks in Patients with Immune Thrombocytopenic Purpura,” eJHaem, vol. 5, no. 3, pp. 431–439, Jun. 2024, doi: 10.1002/jha2.897.

[16] R. M. Alhamawi et al., “The Impact of Hemodialysis on Humoral and Cellular Immunity in Patients with Renal Failure,” J. Clin. Med., vol. 14, no. 18, p. 6533, 2025, doi: 10.3390/jcm14186533.

[17] A.Anitha, P.Sudhakar, and S.Ramapriya, “A Study of Red Blood Cell Indices among Covid 19 Individuals in Tertiary Care Triage Centre,” Int. J. Physiol., vol. 9, no. 4, pp. 1–8, 2021, doi: 10.37506/ijop.v9i4.3085.

[18] X. Deng, X. Gong, Y. Huang, J. Zhou, and S. Ren, “Eryptosis in Renal Anemia: Mechanisms, Clinical Implications, and Therapeutic Targeting,” Front. Pharmacol., vol. 16, pp. 1–18, 2025, doi: 10.3389/fphar.2025.1718803.

[19] O. Dziadkowiec, “Statistical Methods for Pre-Post Intervention Design,” J. Obstet. Gynecol. Neonatal Nurs., vol. 53, no. 1, pp. 9–13, Jan. 2024, doi: 10.1016/j.jogn.2023.11.010.

[20] K. D. Yoo et al., “Red Blood Cell Distribution Width as a Predictor of Mortality Among Patients Regularly Visiting The Nephrology Outpatient Clinic,” Sci. Rep., vol. 11, no. 1, p. 24310, 2021, doi: 10.1038/s41598-021-03530-2.

[21] B. Janssen et al., “Dialyzer Characteristics are Associated with Differential Effects on Intradialytic Microvascular Tissue Perfusion,” Ann. Med. Surg., vol. 88, no. 2, pp. 1369–1382, 2026, doi: 10.1097/MS9.0000000000004738.

[22] Fahima Albeshti and Ayah AL-Hanish, “Hematological Changes in Pre- and Post-Dialysis in Patients Undergoing Hemodialysis: A Comparative Study at Zawia Hospital,” AlQalam J. Med. Appl. Sci., vol. 7, no. 4, pp. 1174–1179, 2024, doi: 10.54361/ajmas. 247438.

[23] S. M. Hutasuhut, A. T. Nasution, and M. Feldy Gazaly Nasution, “Correlation between Red Cell Distribution Width (RDW) with Kidney Function and Hematologic Parameters in Patients Undergoing Regular Hemodialysis,” J. Endocrinol. Trop. Med. Infect. Dis., vol. 2, no. 4, pp. 171–176, 2020, doi: 10.32734/jetromi.v2i4.4732.

Downloads

Published

2026-05-20

Issue

Averrous, Volume 12 No.1 Mei 2026

Section

Articles

License

Copyright (c) 2026 Dzaki Ahmad Fahrezi Amus, Haerani Harun, Jeremy Tanan, Rahma, Nur Syamsi, Christin Rony Nayoan

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors retain copyright and grant the journal right of first publication and this work is licensed under a Creative Commons Attribution-ShareAlike 4.0 that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

All articles in this journal may be disseminated by listing valid sources and the title of the article should not be omitted. The content of the article is liable to the author.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

In the dissemination of articles, the author must declare the AVERROUS: Jurnal Kedokteran dan Kesehatan Malikussaleh Journal as the first party to publish the article.